16 December 2025
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
iCoreConnect Inc.
CIK: 1906133•2 Annual Reports•Latest: 2025-05-30
10-K / May 30, 2025
Revenue:$10,746,466
Income:-$31,156,817
10-K / April 29, 2024
Revenue:$8,151,587
Income:-$15,920,362
10-K / May 30, 2025
Company Summary: iCoreConnect Inc.
Overview
- Type: Cloud-based software and technology company
- Focus: Increasing workflow productivity and customer profitability through an enterprise platform of applications and services.
Recent Developments
- Business Combination:
- Entered into a merger agreement on January 5, 2023.
- Merged with Nevada corporation Old iCore.
- Changed name from FG Merger Corp. to iCoreConnect Inc. after the merger.
- Merger finalized on August 25, 2023, with Old iCore surviving as a wholly owned subsidiary.
- Asset Sale:
- Sold assets related to Managed IT Services (MSP and MSaaS) on October 1, 2024.
- Product Development:
- Developed new products in 2024:
- iCoreVerifyPro: Comprehensive insurance verification service for dental practices.
- iCorePay: Patient billing and payment platform.
- iCoreAcademy: Educational video library for patient education.
- Developed new products in 2024:
Core Products and Services
- SaaS Offerings:
- iCoreRx: HIPAA compliant electronic prescription system, includes support for controlled substances (iCoreEPCS) and integrates with practice management and EHR systems.
- iCorePDMP: Add-on for iCoreRx that provides real-time state prescription drug monitoring database access.
- iCoreVerify / iCoreVerify+: Insurance eligibility verification tools that automate benefit checks; includes concierge support in the plus version.
- iCoreClaims: Claims processing platform for insurance and dental providers, verifying eligibility, managing submissions, adjudication, communication, and record-keeping.
- iCoreHuddle / iCoreHuddle+: Analytics tools for dental practices; provide KPIs, schedule data, outstanding balances, and benefits info.
- iCoreCodeGenius: Medical coding reference tool with ICD-10 and CPT codes, guidance, and suggestions to reduce denials.
- iCoreExchange: Secure, HIPAA-compliant communication platform for email among healthcare professionals and with patients.
- iCoreCloud: Cloud backup solution for practice data, encrypted, fully HIPAA compliant.
- iCorePay: Payment processing platform with digital wallet support, automates billing and improves revenue cycles.
- iCoreSecure: Encrypted email for privacy protection across various industries.
- iCoreClaims & iCoreIT: Healthcare claims management and IT services (note: assets sold in October 2024).
Business Model
- Revenue Type: Primarily from annual recurring subscriptions of SaaS software.
- Customers:
- No significant customer accounts (>10%) identified.
- Revenue generated from a broad base of individual customers.
- Customer concentration is low; accounts receivable with one customer represented about 26% (2024) and 25% (2023) of total receivables.
Employees & Revenue
- Employees: 72 total as of December 31, 2024 (68 full-time).
- Revenue:
- For the fiscal year 2024: $10.75 million (up 32% from $8.15 million in 2023).
- Main growth driven by increased subscription sales and pricing adjustments.
- Income:
- Net loss for 2024: $31.16 million (compared to $15.55 million in 2023).
- Operating loss increased due to higher expenses, impairments, and other charges.
- Significant impairment losses in 2024 on goodwill, customer relationships, and acquired technology due to declining market value and financial stability.
Key Financial Highlights (2024 vs 2023)
- Revenues: +32%
- Net Loss: More than doubled, $31.16 million.
- Employees: 72 (mainly software and management staff).
- Customer base: Multiple individual customers, no single dominant customer. Accounts receivable with one customer at about 26% of total.
Additional Notes
- Company is actively involved in legal proceedings and debt restructuring.
- Business operations are impacted by ongoing liquidity and capital raising needs; substantial doubt exists regarding the ability to continue as a going concern.
- Company has undergone reverse stock split, resulting in 2,066,016 shares outstanding at May 29, 2025.
- Stock was listed on NASDAQ until May 22, 2025; now traded OTC market.
- The company is classified as an emerging growth and smaller reporting company, with certain reduced disclosure requirements.
